Most peptide sites never get found. Not because Google can't crawl them — because there's nothing on the page worth ranking above the dozen deeper pages already there.
We build the ones that do get found, and we can show you the Search Console screenshots.
What you get
End-to-end SEO for research-peptide brands: keyword and intent research, content clusters, technical architecture, on-page optimisation, structured data, internal linking, and the authority work that earns rankings. Built into the site from the first commit, then grown month over month.
Not a checklist someone runs once and invoices for. A system that compounds.
Why most peptide sites stay invisible
Four failures, in roughly this order of frequency.
The content is too thin. This is the big one. Pages under about 500 words essentially don't rank for anything competitive — not because word count is a ranking factor, but because 500 words can't answer a question more thoroughly than the 2,500-word page currently at position three. Most peptide sites are a handful of product pages and an about page, which is not a search footprint.
The keywords are wrong. Founders chase the biggest volume in the category, lose to established domains, and conclude SEO doesn't work. Meanwhile the queries with genuine commercial urgency — payment problems, processor terminations, compliance questions — sit almost uncontested.
The architecture leaks. Canonical tags pointing at a hostname that redirects. Orphan pages nothing links to. Pillar pages thinner than the spokes pointing at them. Individually invisible, collectively expensive.
Nobody keeps going. Ranking compounds only while you feed it. Most competitors stop publishing around month two, which is precisely why there's an opening here at all.
How we approach it
1. Diagnose before prescribing
We start in your Search Console, not in a keyword tool. The first question is whether you're indexed, and the second is what your impressions and average position actually say:
- Indexed, high impressions, position 30+ → a content depth problem
- Indexed, low impressions, good position → a keyword selection problem
- Not indexed → a technical problem
These need completely different work. Most agencies sell the same package regardless.
2. Map keywords to commercial intent
We prioritise by winnability and urgency, not headline volume. In this category the ranking that pays isn't the one with the most searches — it's the one where somebody has an expensive problem right now.
Problem-urgent queries around payments, freezes and reserves are the least competitive and the highest-converting terms available to a peptide brand. We attack those first, then work toward the harder commercial terms as authority accumulates. Peptide keyword research explains the mapping.
3. Build in clusters
Pillar pages that cover a topic properly, supporting articles that go deep on individual questions, internal linking that ties them together and tells Google which page is authoritative.
The four clusters that fit a research-peptide brand: don't-get-shut-down, get-found, start-a-brand, and your money pages. Attack order matters — we start where competition is thinnest and intent is hottest.
4. Fix the technical foundation once
Server-rendered HTML, one canonical hostname with everything agreeing, clean URL structure, fast Core Web Vitals, structured data, a real sitemap. Table stakes — none of it ranks you alone, all of it holds you back if broken.
5. Publish real depth, consistently
The actual differentiator, and the unglamorous one. Specifics, numbers, comparison tables, objections handled, adjacent questions answered, and a genuine operator point of view. Anyone can restate what's already ranking. Very few people in this category can write from having actually done it.
6. Build authority deliberately
Depth gets you from page five to page two. For head commercial terms, external authority is what breaks you through — original data, supplier and processor relationships, industry press in the high-risk payments space. No paid links, no PBNs. In a category already under elevated scrutiny, buying links adds an entirely avoidable second risk.
What makes ours different
- A real track record. We've ranked research-peptide sites page one for commercial keywords — proven in Search Console, not pitched.
- We build and rank. SEO isn't bolted on by a separate vendor. It's designed into the architecture, content and internal linking from the first commit.
- Intent over vanity. We target terms that bring buyers ready to act, not traffic that never converts.
- Category fluency. We know which queries carry commercial urgency here, which carry regulatory risk, and which look attractive and convert nothing.
- Compliance-aware by default. Everything is written research-use-only, with no human-use or dosing language. Credibility without crossing lines — which also matters because underwriters read your content.
What we don't do
- Guarantee rankings. Nobody credible does.
- Buy links or run private blog networks.
- Publish AI filler at volume to hit a word count.
- Write anything with dosing, human-use or therapeutic claims, regardless of what it would rank for.
- Take a client whose site we can't honestly move.
The reporting
Monthly, in plain language: impressions and position by page, which pages entered the top 10, what moved and why, what's next. Filtered to your actual market — if a third of your impressions come from countries you don't serve, headline numbers flatter you and we'd rather they didn't.
We also wire conversion tracking to landing page, so you can see which content produces inquiries rather than guessing.
Where this fits
SEO works best when the site is engineered for it from the start — see peptide website design. The ongoing engine that feeds it is content and blog. If you run a clinic rather than a product brand, peptide therapy SEO covers that landscape.
Want to see the track record and what we'd do with your site specifically? That's the call.